
First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA breast cancer patients
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…
Gabrielle Dunlevy, UNSW A streamlined model of education can be used to offer genetic testing…
Researchers at Peter MacCallum Cancer Centre are calling for greater caution in genetic testing for…
The association between menstrual cycle activity and breast and ovarian cancer risk may have an…
By Julia Medew – SMH. If there was ever any doubt about the magnitude of Angelina…
Scientists at the Salk Institute have uncovered details into a surprising—and crucial—link between brain development…
New guidance published by NICE a “game changer” for UK women with genetic risk of…